Before recommending peptide therapy, our providers may evaluate: Your health goals Current symptoms Injury or recovery concerns Medical history Medication and supplement use Sleep, stress, and lifestyle factors Mental health history Hormonal or metabolic concerns Lab testing when appropriate Safety risks and contraindications If peptide therapy is appropriate, your provider will explain the recommended approach, possible benefits, limitations, risks, and follow-up plan
REDEFINE 1 Results (Phase 3) The landmark trial randomized 3,417 adults to CagriSema 2.4/2.4 mg, semaglutide 2.4 mg alone, cagrilintide 2.4 mg alone, or placebo for 68 weeks (Aronne et al., 2025): The combination significantly outperformed either component alone
This guide covers what is actually in a MIC injection and what each component does, what the evidence supports and what it doesnt, how lipotropics compare to GLP-1s and every other option on the menu, who is a reasonable candidate, the safety profile, and where these injections legitimately fit inside a supervised medical weight loss program
Additionally, it participates in amino acid transport pathways
Full 2026 regulatory status, Category 2 reclassification updates, compounding regulations, and published research